Invention Grant
- Patent Title: TYK2 inhibitors and uses thereof
-
Application No.: US17320394Application Date: 2021-05-14
-
Publication No.: US11834449B2Publication Date: 2023-12-05
- Inventor: Jeremy Robert Greenwood , Craig E. Masse
- Applicant: Nimbus Lakshmi, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Honigman LLP
- The original application number of the division: US16697371 2019.11.27
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00

Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
Public/Granted literature
- US20220106306A1 TYK2 INHIBITORS AND USES THEREOF Public/Granted day:2022-04-07
Information query